Centene Corp. closed 27.80% short of its 52-week high of $80.59, which the company achieved on September 3rd.

Centene's leader said the official's "dynamic business and financial expertise" would benefit the Clayton health care giant.

US managed care insurers' Q4 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to ...

This was the stock's second consecutive day of gains.

Centene Corporation (NYSE: CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, ...

Institutional investors and hedge funds own 93.63% of the company’s stock. Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and ...

LifeStance Health Group, a provider of outpatient mental health care, has named Dave Bourdon as the new CEO, effective 3 ...

Centene Corporation agreed to pay $11.25 million to resolve allegations that a Rancho Cordova- based subsidiary failed to comply with cybersecurity requirements while managing military health plans.

"The settlement makes clear that Glenmark denies each and every one of the allegations against it and the settlement is not ...

Midsize stocks are not so big they become stagnant and not too small to be risky.

Glenmark Pharmaceuticals settles U.S. lawsuits for $7 million related to generic drugs, denying all allegations.